Abumiya, M., Takahashi, N., Takahashi, S., Yoshioka, T., Kameoka, Y., & Miura, M. (2021). Effects of SLC22A2 808G>T polymorphism and bosutinib concentrations on serum creatinine in patients with chronic myeloid leukemia receiving bosutinib therapy. Nature Portfolio.
Cita Chicago Style (17a ed.)Abumiya, Maiko, Naoto Takahashi, Saori Takahashi, Tomoko Yoshioka, Yoshihiro Kameoka, y Masatomo Miura. Effects of SLC22A2 808G>T Polymorphism and Bosutinib Concentrations on Serum Creatinine in Patients with Chronic Myeloid Leukemia Receiving Bosutinib Therapy. Nature Portfolio, 2021.
Cita MLA (8a ed.)Abumiya, Maiko, et al. Effects of SLC22A2 808G>T Polymorphism and Bosutinib Concentrations on Serum Creatinine in Patients with Chronic Myeloid Leukemia Receiving Bosutinib Therapy. Nature Portfolio, 2021.